Inoxgen

Nitric Oxide, the active ingredient in Inoxgen, is a vasodilator presented as a gas for inhalation use. It is employed to manage pulmonary hypertension in both neonates and adults, facilitating relaxation of pulmonary vascular smooth muscle and improving oxygenation. GNH USA supplies Inoxgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, adhering to stringent quality standards and providing regulatory support for global distribution.

Inoxgen, a pulmonary vasodilator, is used in conditions characterized by elevated pulmonary arterial pressure.

Neonatal pulmonary hypertension: improves pulmonary blood flow and oxygenation in newborns. Adult pulmonary hypertension: reduces pulmonary vascular resistance and alleviates symptoms. Pulmonary arterial hypertension (PAH): helps lower mean pulmonary artery pressure and improve exercise capacity.

Inoxgen may cause a range of adverse reactions.

Common Side Effects: - Cough or throat irritation - Headache - Flushing or warmth sensation - Mild hypotension - Nausea or dizziness

Serious or Rare Side Effects: - Methemoglobinemia - Severe hypotension or cardiovascular collapse - Pulmonary edema - Bronchospasm or respiratory distress - Allergic reactions such as rash or anaphylaxis

Use Inoxgen with careful monitoring of hemodynamic status. - Blood pressure monitoring: observe for hypotension during and after administration. - Caution in patients with pre‑existing hypotension or cardiovascular instability. - Avoid in individuals with methemoglobin reductase deficiency. - Assess liver and kidney function before initiating therapy. - Do not combine with other potent pulmonary vasodilators without specialist guidance. - Store at room temperature: keep cylinder upright, protect from heat and direct sunlight.

Inoxgen can interact with several drug classes.

Major Interactions (Avoid): - Phosphodiesterase‑5 inhibitors (e.g., sildenafil) – risk of profound hypotension. - Inhaled anesthetics such as nitrous oxide – additive vasodilatory effect. - Other pulmonary vasodilators (e.g., prostacyclin analogs) – may cause excessive pulmonary pressure drop.

Moderate Interactions (Monitor Closely): - Systemic antihypertensives – may enhance blood pressure lowering. - Anticoagulants – potential increased bleeding risk. - Bronchodilators – may affect respiratory response to nitric oxide.